|
| Read more ›› |
|
By: GlobenewsWire - 16 Dec 2020
|
|
Related companies:
BioNTech SE |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 16 Dec 2020
|
|
Related companies:
Grünenthal Group |
|
|
| Read more ›› |
|
By: GlobenewsWire - 15 Dec 2020
|
|
Related companies:
Burning Rock Biotech |
Brenntag GmbH |
|
|
| Back-end-of-line compatible architecture paves the way to high-density 3D-DRAM memories Read more ›› |
|
By: PR Newswire Association LLC. - 15 Dec 2020
|
|
|
| - On the back of highly promising Phase Ib data, MinervaX has raised financing from leading investors to accelerate development of its novel vaccine through the end of Phase II trials and preparations for Phase III pivotal trials;- Sanofi Ventures, Wellington Partners, Adjuvant Capital, and Industrifonden... Read more ›› |
|
By: PR Newswire Association LLC. - 15 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 15 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 14 Dec 2020
|
|
|
| Samsung Catalyst Fund, MIG AG, Storm Ventures, Benhamou Global Venturesand IT Farm invest in the robotics technology leader for industrial exoskeletons Read more ›› |
|
By: PR Newswire Association LLC. - 14 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 14 Dec 2020
|
|
Related companies:
BioNTech SE |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 14 Dec 2020
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 14 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 12 Dec 2020
|
|
Related companies:
BioNTech SE |
|
|
| Read more ›› |
|
By: GlobenewsWire - 11 Dec 2020
|
|
|
| - Five-year outcomes from large, prospective phase III ADAPT study confirm value of the test to help guide treatment decisions in breast cancer patients with high clinical risk, including those with node-positive disease;- New meta-analysis of data from more than 10,000 patients with node-negative... Read more ›› |
|
By: PR Newswire Association LLC. - 11 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 11 Dec 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 11 Dec 2020
|
|
Related companies:
BioNTech SE |
|
|
| Read more ›› |
|
By: GlobenewsWire - 10 Dec 2020
|
|
Related companies:
BioNTech SE |
|
|
| - Gilead to Acquire Hepcludex™, a First-in-Class Entry Inhibitor, for Treatment of Chronic Hepatitis Delta Virus (HDV), Adding Immediate Revenue After Closing of Transaction -;- Hepcludex Was Conditionally Approved in Europe in July 2020 Based on Phase 2 Data and Submission for Accelerated Approval... Read more ›› |
|
By: PR Newswire Association LLC. - 10 Dec 2020
|
|
Related companies:
MYR Pharmaceuticals |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 09 Dec 2020
|
|
Related companies:
Sartorius AG |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Dec 2020
|
|
Related companies:
Centogene N.V. |
|
|
|
|
|
Biotechgate Global Database ›
